PMID: 2555512 PMC1572913 Pigmentation Pathway (MC1R, Preclinical) Eumelanin upregulation via cAMP / MITF / tyrosinase axis MC1R activation by melanocortin agonists is reported to raise intracellular cAMP, upregulate MITF, and increase tyrosinase-mediated eumelanin synthesis in epidermal melanocyte models
After reconstitution: Store at 28 C , protect from light, and avoid repeated temperature cycling
Both medications can support substantial weight reduction in appropriately selected patients, but they use different hormone pathways and have different FDA-labeled uses
These residues have been associated with wide range of toxic effects in animals such as cattle, sheep, and poultry, particularly affect liver, kidney, and neurological toxicities
, ( )
Mulvihill, M